IRIS
LASCO, Antonino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.890
NA - Nord America 7.117
AS - Asia 4.443
SA - Sud America 1.402
AF - Africa 112
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.978
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.970
RU - Federazione Russa 4.652
SG - Singapore 1.836
CN - Cina 1.429
BR - Brasile 1.170
IE - Irlanda 1.082
SE - Svezia 949
DE - Germania 566
IT - Italia 487
HK - Hong Kong 440
FR - Francia 321
FI - Finlandia 245
VN - Vietnam 245
GB - Regno Unito 168
UA - Ucraina 136
IN - India 135
PL - Polonia 106
AR - Argentina 80
CA - Canada 77
TR - Turchia 53
BD - Bangladesh 51
EC - Ecuador 44
IQ - Iraq 41
MX - Messico 37
BE - Belgio 34
NL - Olanda 32
VE - Venezuela 30
PK - Pakistan 28
ZA - Sudafrica 23
ES - Italia 22
JP - Giappone 21
MA - Marocco 21
CL - Cile 20
CO - Colombia 20
UZ - Uzbekistan 20
EG - Egitto 15
ID - Indonesia 15
PY - Paraguay 15
AT - Austria 14
CZ - Repubblica Ceca 14
JO - Giordania 14
PH - Filippine 13
SA - Arabia Saudita 13
UY - Uruguay 11
CI - Costa d'Avorio 10
AZ - Azerbaigian 9
CH - Svizzera 9
DZ - Algeria 9
LT - Lituania 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
KE - Kenya 8
NP - Nepal 8
JM - Giamaica 7
KZ - Kazakistan 7
SN - Senegal 7
AL - Albania 6
BG - Bulgaria 6
CU - Cuba 6
DO - Repubblica Dominicana 6
IL - Israele 6
KG - Kirghizistan 6
KR - Corea 6
MY - Malesia 6
PE - Perù 6
TN - Tunisia 5
BH - Bahrain 4
BO - Bolivia 4
ET - Etiopia 4
GT - Guatemala 4
HN - Honduras 4
HU - Ungheria 4
IR - Iran 4
RO - Romania 4
BN - Brunei Darussalam 3
DK - Danimarca 3
EE - Estonia 3
GE - Georgia 3
LV - Lettonia 3
NG - Nigeria 3
XK - ???statistics.table.value.countryCode.XK??? 3
BY - Bielorussia 2
GR - Grecia 2
GY - Guiana 2
HR - Croazia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MU - Mauritius 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
EU - Europa 1
GA - Gabon 1
Totale 21.959
Salva come PNG Salva come JPEG
Città #
Moscow 1.256
Ashburn 1.123
Dublin 1.080
Singapore 1.023
Chandler 781
Dallas 693
Nyköping 514
Beijing 499
Hong Kong 414
San Jose 395
Jacksonville 373
Munich 257
The Dalles 241
Princeton 194
Dearborn 189
Los Angeles 161
New York 157
Medford 153
Lauterbourg 148
Messina 147
Ann Arbor 145
Cambridge 133
Bremen 124
Des Moines 118
Boardman 102
Warsaw 92
São Paulo 90
Ho Chi Minh City 85
Helsinki 78
Guangzhou 72
Jinan 67
Tianjin 63
Buffalo 62
Shenyang 57
Turku 54
Hanoi 53
Nanjing 50
San Mateo 48
Frankfurt am Main 46
Wilmington 46
Catania 43
Pune 43
Redondo Beach 43
Orem 40
Houston 38
Lancaster 36
Woodbridge 36
Rio de Janeiro 34
Santa Clara 34
Brussels 33
Seattle 33
Belo Horizonte 30
Council Bluffs 29
Curitiba 29
Hebei 28
Zhengzhou 27
Haikou 26
Hangzhou 25
Brasília 24
Brooklyn 24
Chennai 24
Montreal 24
Nanchang 24
Düsseldorf 23
Boston 21
Nuremberg 21
Taizhou 21
Baghdad 20
Denver 18
Hyderabad 18
London 18
Strasbourg 18
Tashkent 18
Johannesburg 17
Porto Alegre 17
Ningbo 16
Quito 16
Tokyo 16
Chicago 15
Fuzhou 15
Poplar 15
Toronto 15
Amsterdam 14
Jiaxing 14
San Francisco 14
Manchester 13
Rome 13
Taiyuan 13
Atlanta 12
Goiânia 12
Lahore 12
Manaus 12
Ankara 11
Changsha 11
Istanbul 11
Lanzhou 11
Milan 11
Stockholm 11
Abidjan 10
Amman 10
Totale 12.663
Salva come PNG Salva come JPEG
Nome #
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 292
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 237
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 226
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 224
Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity 223
Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride (Clinical Drug Investigation, (2018), 10.1007/s40261-018-0720-7) 220
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 219
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 219
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 216
Anxiety levels predict low bone mineral density in postmenopausal women assessed for osteoporosis. 213
ASSOCIAZIONE TRA IMPULSIVITÀ COGNITIVA E DENSITÀ MINERALE OSSEA: STUDIO CROSS-SECTIONAL SU DONNE VALUTATE PER OSTEOPOROSI POSTMENOPAUSALE 208
Applicazione quantitativa dell'ultrasonografia ossea quantitativa e dell'Hand grip nello screening per l'osteoporosi e per il rischio di frattura in donne in post-menopausa, condotto con l'algoritmo FRAX 201
Anabolic treatment with RHPTH of duchenne muscular dystrophy related osteoporosis: a case report 195
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 192
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 189
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 188
ASSOCIAZIONE TRA LIVELLI DI ANSIA E VITAMINA D IN DONNE IN ETÀ POSTMENOPAUSALE VALUTATE PER OSTEOPOROSI 187
Hyponatremia as a leading sign of hypopituitarism 186
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 185
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 182
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors 179
ANXIETY LEVELS ARE ASSOCIATED WITH FRACTURE RISK IN POSTMENOPAUSAL WOMEN 177
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 175
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 175
Circulating sclerostin and Dickkopf-1 correlate with vascular calcifications in non-dialysis chronic kidney disease 173
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 172
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 172
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 172
PULSED ELECTROMAGNETIC FIELDS AFFECT SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 171
Anxiety levels as risk factor for osteoporosis in postmenopausal women 168
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 167
HEMOSTATIC VARIABLES IN ARTERIAL-HYPERTENSION 167
Deficit multiplo di AcilCoA deidrogenasi ad esordio tardivo. Descrizione di un caso clinico. 167
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 166
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 166
HANDGRIP STRENGHT AND PHALANGEAL QUANTITATIVE ULTRASOUND IN THE FRACTURE RISK ASSESSMENT OF POSTMENOPAUSAL WOMEN 165
Frailty and lipid profile in elderly hospitalized patients 165
Descrizione di un caso di pielonefrite in ultranovantenne: complicanza extraintestinale di un fecaloma gigante. 165
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 163
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 163
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 163
IL-22 circulating serum levels in centenarians. 161
Healthy centenarians show high levels of circulating interleukin-22 (IL-22). 160
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 160
Cognitive impulsivity is associated with bone mineral density and history of falls in postmenopausal women. 158
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 157
Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate 157
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 156
Vitamin D modulates bmd gain in postmenopausal women treated with strontium ranelate 156
ANXIETY SEVERITY AS A PREDICTOR OF OSTEOPOROSIS 155
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 154
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 154
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 154
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 154
Sincope conseguente a severa depressione della conduzione atrio-ventricolare trattata con impianto di Pace-maker in un soggetto anziano affetto da fibrillazione atriale permanente e demenza in trattamento con rivastigmina 153
VALUTAZIONE NEUROPSICOLOGICA IN SOGGETTI ANZIANI AFFETTI DA IPERTROFIA PROSTATICA BENIGNA IN TRATTAMENTO CON DUTASTERIDE 153
Frailty modifications and prognostic impact in older patients admitted in acute care 153
Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina. 152
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 151
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 151
FRAGILITÀ E PROFILO LIPIDICO IN UN GRUPPO DI PAZIENTI ANZIANI OSPEDALIZZATI 151
Effects of medium-term antihypertensive therapy on haemostatic parameters in patients with essential hypertension 149
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 149
SUBCLINICAL HYPERCORTISOLISM IS A RISK FACTOR TO BE EVALUATED IN THE ASSESSMENT OF BONE FRAGILITY? 148
Valutazione e comparazione del filtrato glomerulare stimato con due differenti formule in una popolazione di centenari 148
Serum levels of Apelin-36 are decreased in older hospitalized patients with heart failure 148
Cognitive impulsivity is associated with bone mineral density in postmenopausal women evaluated for osteoporosis. 147
Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis 147
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 146
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 146
Are Physicians Ready to Prevent Osteoporotic Fractures in Hemodialysis Patients? 145
Handgrip and phalangeal quantitative ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis. 145
Relationship between blood pressure and frailty in older hypertensive outpatients 145
Handgrip and phalangeal ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis 144
Phalangeal quantitative ultrasound as assessment tool to evaluate bone loss in aromatase inhibitors related osteoporosis 144
Estimating glomerular filtration rate in centenarians: comparison of the chronic kidney disease epidemiology collaboration (CKD-EPI) and modification of diet in renale disease (MDRD) study equation 143
In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia 143
WNT/beta-CATENIN AND RANK/RANKL/OPG SIGNALLING MODULATES EFFECTS OF PULSED ELECTROMAGNETIC FIELDS ON BONE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 143
Electrocardiographic changes in centenarians: a study on 42 subjects and comparison with the literature 142
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 142
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: New pieces of the puzzle 141
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 140
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 140
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 139
Calcifediol improves lipid profile in atorvastatin treated postmenopausal women 139
Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride 139
Impact of diabetes on cognitive impairment and disability in elderly hospitalized patients with heart failure 137
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 137
BONE MINERAL DENSITY MODIFICATIONS IN ACCORDANCE TO VITAMIN D STATUS IN POSTMENOPAUSAL WOMEN TREATED WITH STRONTIUM RANELATE 137
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 136
Cognitive Impairment and Slow Gait Speed in Elderly Outpatients with Arterial Hypertension: The Effect of Blood Pressure Values 136
Impact of Premorbid IQ and Cognitive Reserve on Clinical and Functional Outcomes in Elderly Outpatients 136
Does vitamin D3 have an impact on clinical and biochemical parameters related to third molar surgery 135
Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study 135
Pulsed electromagnetic fields modulate sclerostin levels in women with postmenopausal osteoporosis 133
Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis 132
Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors 132
DISAPPEARANCE OF A VIRILIZING ADRENAL TUMOR FOLLOWING THERAPY WITH CYPROTERONE ACETATE. 131
Effetti del raloxifene sulla secrezione ipofisaria in post-menopausa 131
Serum levels of apelin-36 are decresed in elderly hospitalized patients with heart failure 130
Totale 16.333
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.930
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 0 0 0 0 0 0 45
2021/20221.303 10 183 21 54 33 9 106 39 122 210 127 389
2022/20233.155 225 332 153 206 307 286 21 175 1.314 15 88 33
2023/2024811 62 135 34 107 57 189 19 58 6 27 12 105
2024/20253.519 55 58 61 213 180 111 115 675 898 230 328 595
2025/202610.664 588 845 618 693 899 2.219 1.275 1.471 1.397 416 143 100
Totale 22.303